The TME of group 4 (CDKN2A LoF only) was not significantly different to that of 9p21 wild-type samples in both NP-BE and P-BE, confirming that CDKN2A LoF does not directly interfere with the immune system. Here, CDKN2A is linked to Barrett esophagus.